About

Publications While At HealthPartners

selected publications

Journal Article

Association of fenofibrate therapy with long-term cardiovascular risk in statin-treated patients with type 2 diabetes. 

JAMA cardiology. 2017

Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial. 

Diabetes care. 2014

Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. 

Diabetes care. 2012

Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. 

Lancet Neurology. 2011

Effects of combination lipid therapy in type 2 diabetes mellitus. 

New England Journal of Medicine. 2010

Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Am J Cardiol

2007

Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 

American Journal of Cardiology. 2007

presentations

Presentation

Effect of fenofibrate therapy on cardiovascular disease in men vs women with type 2 diabetes in the ACCORD-Lipid Trial [presentation], American Heart Association (AHA) Scientific Sessions

Hypertriglyceridemia and low HDL-C predicts fenofribrate response in the ACCORD-Lipid Trial [presentation], American Heart Association (AHA) Scientific Sessions

Contact

full name

LC Lovato

L. C. Lovato

Quick Info

Publications

Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.

Collaboration

Co-author network

Map of science